Tg(Prnp-SETX*R2136H)1920Als
Transgene Detail
|
Symbol: |
Tg(Prnp-SETX*R2136H)1920Als |
Name: |
transgene insertion 1920, Albert La Spada |
MGI ID: |
MGI:6881754 |
Synonyms: |
R2136H Tg (line 1920) |
Transgene: |
Tg(Prnp-SETX*R2136H)1920Als Location: unknown
|
Alliance: |
Tg(Prnp-SETX*R2136H)1920Als page
|
|
Strain of Origin: |
Not Specified
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Prnp-SETX*R2136H)1920Als expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
SETX (23064) |
|
R2136H mutation seen in ALS4 patients |
|
|
|
Mutation details: The human SETX cDNA containing an arginine to histidine substitution at amino acid 2136 (R2136H; c.6407G>A) is under the control of the mouse prion promoter. The R2136H mutation is one of two identified to date in individuals with amyotrophic lateral sclerosis type 4 (ALS4). Two lines were established: 1917 and 1920. Line 1920 shows expression of the transgene at approximately 2.5X that of the endogenous mouse gene.
(J:320844)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:320844 Bennett CL, et al., Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients. Acta Neuropathol. 2018 Sep;136(3):425-443 |
All: |
1 reference(s) |
|